Back to Results
First PageMeta Content
Pharmaceuticals policy / Drugs / Clinical pharmacology / Food and Drug Administration / David Hager / Emergency contraception / Over-the-counter drug / Contraception / Prescription medication / Medicine / Health / Pharmacology


News Reports About FDA Advisor Raise New Questions About Agency’s Refusal to Approve Over-the-Counter Plan B Statement by Kirsten Moore, President of Reproductive Health Technologies Project For immediate release May 1
Add to Reading List

Document Date: 2005-05-12 18:05:59


Open Document

File Size: 104,30 KB

Share Result on Facebook

City

WASHINGTON / DC / /

Company

Reproductive Health Technologies Project / /

IndustryTerm

over-the-counter product / ground solution / /

MedicalTreatment

birth control / emergency contraception / /

Organization

FDA / Food and Drug Administration’s Reproductive Health Drugs Advisory Committee / /

Person

Lester Crawford / David Hager / Bush / Kirsten Moore / Andrea Miller / /

/

Position

physician / inappropriate government adviser / Advisor / President / Commissioner / /

ProgrammingLanguage

DC / /

URL

www.rhtp.org / /

SocialTag